The unveiling of Disney+ and Apple TV+ certainly hasn’t made life easier for Netflix. The new streaming services come with single-digit dollar monthly prices that make Netflix seem more like a luxury than a necessity.
Laura Martin, Needham analyst, argues that Netflix should consider an ad-supported platform at about half of the platform’s current price, but since Netflix has long insisted on not going down this path, Martin believes that the best course of action is for the company to put itself up for sale. She realizes that there are not too many companies that can afford Netflix. The company is worth nearly $140 billion, and if you add a 30% premium that might be needed to close, that drives the price up to over $180 billion.
There are only 35 companies with market capitalization in excess of $180 billion and although some of them are technology and entertainment companies – including Apple and Disney, many are not ideal as potential buyers. Let’s look at Comcast, Apple, and AT&T, three of the giants that have something to gain from taking over Netflix.
Born2Invest brings you the latest business headlines from around the world and across the spectrum of the trusted global network. Keep up to date with the latest stories, and content on a whole range of topics, from an African perspective, business to finance, industries, biotech and much more.
The analyst specifically mentions Comcast as a logical buyer one that is likely to bite the bullet for not buying Netflix when the company was cheaper. There was speculation about a Comcast buyout five years ago when Netflix had a market capitalization of less than $30 billion.
Laura Martin believes that a purchase of Netflix by Comcast would be badly perceived by the market now, as Comcast did not take advantage of a lower price years ago, but Comcast needs Netflix now more than five years ago.
Xfinity is expanding its broadband platform but has 612,000 fewer cable TV subscribers than last year. The revolution of switching from TV to streaming is real and the introduction of Peacock – its long-overdue streaming service – next year might be a little too late. Buying Netflix with its market leadership would be a powerful combination.
One year after the Sky takeover, the company now needs a new win to offset the organic losses in value year-on-year. Martin believes Netflix could earn $6 per month per customer from advertising and the company could use this to lower its monthly prices. Netflix would never go down this road, but Comcast would not bat an eyelid.
Apple is now the world’s most valuable company in terms of market capitalization, and it is sitting on a mountain of money. Apple TV+ isn’t making the same waves as Disney+, and that leads us to Netflix. Apple is all about premium services and that’s what Netflix currently offers.
Netflix would make a worthy addition to Apple’s on-demand premium digital rental and sales. Apple TV+ subscribers get multiple options for new or recent movies, offered as one-time digital rentals or online purchases. Apple would love to get its hands on Netflix’s 158 million+ premium accounts and would have no problem drawing these customers deeper into the Apple ecosystem.
A telecom giant buying Netflix would not be a surprise. Just like Comcast, AT&T is losing Pay TV customers at an alarming rate. AT&T has already closed a major content deal with Time Warner, but now it needs a greater platform reach.
Netflix is fulfilling many of AT&T’s dreams here, in part because it could also enhance AT&T’s thriving wireless offerings by bundling Netflix access with smartphone tariffs, as some of its rivals are doing with Disney+. AT&T may be the least likely buyer of the three, especially since it is currently having problems on other fronts. But AT&T could be desperate enough to generate new growth.
Whilst Netflix is unlikely to be sold in the next year or so if the company continues to run into problems one of its competitors may see an opportunity to purchase a thriving subscriber base at a hefty discount within the next 2-3 years.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Vestors Capital, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Top 10 Forex Risks To Consider Before Starting Currency Trade
This article shows you the fx risk to expect while performing forex trade and how to mitigate them and ensure...
Why are investments in the fintech sector set to break records this year
The fintech sector has had a great year so far, according to investor Humberto Herrera Rincón Gallardo, who thinks that...
Biotech companies are getting closer to find the eagerly awaited COVID-19 vaccine
Moderna agreed to sell its coronavirus drug at a "pandemic price" of $32-37 per dose.The biotech company registered losses of...
Switzerland returns $35.6 million to cannabis light producers
Swiss companies producing light cannabis products have received $35.6 million (€30 million) from the customs authorities for illegal taxes previously...
The iCashly finance management app campaign overfunds within an hour of launch
iCashly is a new finance management app that is about to be launched, after succeeding to overfund the crowdfunding campaign...
Business7 days ago
How to keep people on your website longer
Biotech6 days ago
The Spanish pharma sector increased its profit by 18.4% in the first semester of the year
Business6 days ago
The financial guide for newlywed millennials
Featured5 days ago
The Italian fintech company Fido closes a €1.1 million financing round